Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by MrMonkon Oct 29, 2013 1:26pm
262 Views
Post# 21858615

NOX Investor Relations

NOX Investor RelationsI've been quiet lately - very busy with my company, not a lot of spare time.  Here's an update from IR this morning (from DP - word-for-word - anyone could get this same update):

It's nothing new. Hopefully yesterday was the low. 2 big shareholders (funds) have been selling since Aug. One is done today, one has sold ½ and may be done. (Might be separate accounts) They don’t tell us, I can only guess from the trading I see. Insiders have been buying as much as possible. We still have close to $4,000,000 in the till and are planning the next drill program. Once drilling has started we expect to do some road shows in Toronto, NY, etc to get the story out.
 
3 mining companies are reviewing data at Marban for a potential partner to replace Hecla. The last drilling we announced extended the Norlartic deposit to 1.2 km, with the latest results now parallel with the Marban deposit, which means we will likely have ore in the Marban pit hanging wall, which would reduce the waste rock and increase the economics of the pit.


- MM

<< Previous
Bullboard Posts
Next >>